🇺🇸 FDA
Patent

US 9751931

Hepatitis C virus neutralizing antibodies and methods

granted A61KA61K2039/5256A61K39/29

Quick answer

US patent 9751931 (Hepatitis C virus neutralizing antibodies and methods) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/5256, A61K39/29, A61K45/06